Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sera Prognostics, Biomarker Strategies

Premium

Sera Prognostics has named Ilia Ichetovkin vice president of lab operations where he will head development and deployment of the company's CLIA lab services and the commercial launch of its proteomic test to predict preterm birth risk.

Ichetovkin formerly was head of oncology at Vela Diagnostics, director of US lab operations with LabCorp Clinical Trials, and head of clinical diagnostics and biomarker development at Abraxis Bioscience.


Biomarker Strategies has appointed Jack Davis as executive chairman. He will serve as both chairman of the board and as the senior strategic management adviser for the firm.

Davis was a co-founder, president, CEO, chairman, and chief operating officer of Dianon Systems, and he also was division vice president and general manager of Abbott Diagnostics' diagnostic products unit.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.